SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,333,000 | +148.2% | 46,172 | +382.4% | 0.16% | +144.8% |
| Q3 2019 | $1,343,000 | -27.8% | 9,571 | -27.3% | 0.07% | -21.2% |
| Q3 2018 | $1,860,000 | -24.1% | 13,171 | -16.0% | 0.08% | -15.0% |
| Q2 2018 | $2,452,000 | +16.5% | 15,671 | -53.6% | 0.10% | -6.5% |
| Q3 2017 | $2,105,000 | +6.8% | 33,800 | +25.1% | 0.11% | +62.1% |
| Q2 2015 | $1,971,000 | +215.4% | 27,009 | +58.0% | 0.07% | +187.0% |
| Q4 2014 | $625,000 | – | 17,089 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |